| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | VANI | Common Stock | Purchase | $174K | +74.9K | +0.69% | $2.33 | 10.9M | May 31, 2022 | See footnote | F1, F5 |
| transaction | VANI | Common Stock | Purchase | $299K | +132K | +1.21% | $2.26 | 11.1M | Jun 1, 2022 | See footnote | F2, F5 |
| transaction | VANI | Common Stock | Purchase | $246K | +105K | +0.95% | $2.34 | 11.2M | Jun 2, 2022 | See footnote | F3, F4, F5 |
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.17 to $2.40, inclusive. The reporting person undertakes to provide to Second Sight Medical Products, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. |
| F2 | The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.22 to $2.39, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. |
| F3 | The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.28 to $2.38, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. |
| F4 | The Gregg G. Williams 2006 Trust ("GW Trust") acquired 74,870 shares of common stock on May 31, 2022, 132,461 shares of common stock on June 1, 2022 and 105,162 shares of common stock on June 2, 2022. Mr. Williams is a trustee of the GW Trust. |
| F5 | After giving effect to the transactions reported on this Form 4, shares beneficially owned by Mr. Williams include (i) 4,852,133 shares of common stock and warrants to purchase 1,713,599 shares of common stock owned by GW Trust, (ii) 3,638,568 shares of common stock and warrants to purchase 3,453,038 shares of common stock owned by Williams International Co. LLC (iii) 544,760 shares of common stock owned by Sam Williams Family Investments LLC and (iv) 2,193,926 shares of common stock and warrants to purchase 863,259 shares of common stock owned by GST. Includes 25,636 shares of common stock issuable to Mr. Williams upon exercise of options. Greg Williams has voting and dispositive power over all of these shares. |